The DOI matches its Crossref record.
The efficacy of curcuminoids in improvement of ulcerative colitis symptoms and patients’ self‐reported well‐being: A randomized double‐blind controlled trial
Abstract
Background: Curcuminoids are polyphenols with documented anti‐inflammatory activity and has been shown to improve the symptoms of several inflammatory diseases. We aimed to evaluate the effectiveness of a nanoformulation of curcuminoids in the treatment of ulcerative colitis. Methods: This randomized double‐blinded controlled trial was conducted on 56 patients aged 18 years or older with the final diagnosis of mild to moderate ulcerative colitis according to the Simple Clinical Colitis Activity Index (SCCAI). The patients were randomly assigned (using a computerized random sampling table) to receive curcuminoids nanomicelles (80 mg, three times daily, orally) plus mesalamine (3 g/24 hours, orally) as the treatment group and placebo plus mesalamine (3 g/24 hours, orally) as the control group for a period of four weeks. The severity of disease was assessed at baseline and at the end of the second and fourth weeks of the treatment according to the SCCAI. Results: The score for urgency of defecation reduced significantly more in case group as compared with control group at four weeks after beginning the treatment. The patients in case group experienced better general condition than the control ones after 4 weeks of treatment. Overall, the mean SCCAI score was significantly lower in the patients received curcuminoids nanomicelles plus mesalamine as compared with the group received placebo plus mesalamine at fourth week after the treatment (1.71 ± 1.84 vs 2.68 ± 2.09, p = 0.050). Conclusion: Adding curcuminoids nanomicelles to routine treatment of patients with ulcerative colitis is associated with a significant improvement of symptoms, including reduced frequency of urgent defecation, improved patients’ self‐reported well‐being and reduced clinical activity of ulcerative colitis. ClinicalTrials. “IRCT2017052634142N1”.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One study did not report baseline data from which a difference of differences could be calculated (Masoodi et al., 2018); however, no significant difference between groups was calculated at the final follow-up (mean difference SCCAI = À0.97 [SE = 0.53]).”
From A systematic review of the efficacy and safety of turmeric in the treatment of digestive disorders (2024) · cites this paper as Masoodi et al., 2018
In the citing paper
“For bio-enhanced curcumin, the distribution of wellbeing responses for the curcumin group was not significantly different from that of the placebo group after 2 weeks of treatment ( p = 0.455); however, by the end of the 4-week treatment period, well-being responses approached a statistically significant difference favoring the curcumin group ( p = 0.050) (Masoodi et al., 2018).”
From A systematic review of the efficacy and safety of turmeric in the treatment of digestive disorders (2024) · cites this paper as Masoodi et al., 2018
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 34
- 10.1136/bmj.320.7242.1119 · DOI
- 10.1016/S0140-6736(16)32126-2 · DOI
- 10.3748/wjg.v20.i28.9458 · DOI
- MalekzadehR MirmadjlesiH VarshoesazJ AgahS TavakoliHRising the incidence of crohn's disease in iran during last decade(1989–1999). Gastroenterology 118:A1356. · DOI
- Masoodi M, 2012, Estimation of ulcerative colitis incidence in Hormozgan Province, Southern Iran, Govaresh, 16, 265
- Ye Y, 2015, The epidemiology and risk factors of inflammatory bowel disease, Int J Clin Exp Med, 8, 22529
- Meier J, 2011, Current treatment of ulcerative colitis, World J Gastroenterol, 17, 3204
- 10.1007/s12328-016-0686-z · DOI
- 10.1097/FJC.0000000000000406 · DOI
- 10.3109/19390211.2014.952865 · DOI
- 10.1055/s‐0044‐101752 · DOI
- 10.1002/ptr.5659 · DOI
- 2016, Curcumin as a MicroRNA regulator in cancer: A review reviews of physiology, Biochemistry and Pharmacology, 171, 1
- 10.1016/j.nut.2016.04.007 · DOI
- 10.5114/aoms.2017.69326 · DOI · Paper page
- 10.1016/j.clnu.2014.12.019 · DOI
- 10.1016/j.phrs.2016.03.026 · DOI
- 10.3109/19390211.2015.1008611 · DOI
- 10.1016/j.jff.2015.01.005 · DOI
- 10.1002/ijc.30224 · DOI
- 10.1016/j.phymed.2009.05.020 · DOI
- 10.1007/978-0-387-46401-5_3 · DOI
- 10.1007/s00018-008-7452-4 · DOI
- 10.1016/j.bmcl.2015.04.077 · DOI
- 10.1016/j.drudis.2016.03.007 · DOI
- 10.1016/j.cgh.2015.02.019 · DOI · Paper page
- 10.1016/j.hermed.2017.05.002 · DOI
- 10.1016/j.cgh.2006.08.008 · DOI · Paper page
- 10.1007/s10620-005-3032-8 · DOI
- 10.4292/wjgpt.v8.i2.147 · DOI · Paper page
- 10.4143/crt.2014.46.1.2 · DOI
- 10.1248/bpb.34.660 · DOI · Paper page
- 10.1158/1940-6207.CAPR-10-0006 · DOI · Paper page
- 10.1016/j.drudis.2011.09.009 · DOI
Cited by
A systematic review of the efficacy and safety of turmeric in the treatment of digestive disorders
Thavorn, K., Wolfe, D., Faust, L., Shorr, R., Akkawi, M., Isaranuwatchai, W., Klinger, C., Chai‐Adisaksopa, C., Tanvejsilp, P., Nochaiwong, S., et al. (2024) · Phytotherapy Research · doi:10.1002/ptr.8189 · Cited by 11
Metadata
- Authors
- Masoodi, M., Mahdiabadi, M. A., Mokhtare, M., Agah, S., Kashani, A. H. F., Rezadoost, A. M., Sabzikarian, M., Talebi, A., & Sahebkar, A.
- Affiliations
- Colorectal Research Center Iran University of Medical Sciences Tehran Iran
- Neurogenic Inflammation Research Center Mashhad University of Medical Sciences Mashhad Iran
- Venue
- Journal of Cellular Biochemistry
- Publisher
- Wiley
- Published
- 2018-08-21
- Volume
- 119
- Issue
- 11
- Pages
- 9552-9559
- ISSN
- 0730-2312
- 1097-4644
- Cited by
- 75
- References
- 0
- Language
- en
- Funders
- Iran University of Medical Sciences (29694)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
